Abstract
Nowadays, Nontuberculous mycobacteria (NTM) that cause pulmonary and extrapulmonary diseases are on the rise worldwide. However, differential diagnosis between pathology and resident bacteria (pathogen carriers) is often difficult. Besides, treating diseases caused by NTM is still a challenge, there is currently no optimal regimen for each species, and multi-drug regimens need to be specifically adjusted for each patient. Therefore, the purpose of this review is to address the epidemiology of the microbiological etiology of infections caused by NTM and these update the recommendations of the American Thoracic Society (ATS), the European Respiratory Society (ERS), European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA) (2020), and the latest consensus guidelines on diagnosis, treatment, and management NTM of the Ministry of Health of Vietnam (2024), all of which are useful guidelines for diagnosing and treating pulmonary disease caused by NTM in current clinical practice in Vietnam.
| Published | 2025-09-16 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 15 No. 5 (2025) | |
| Section | Reviews | |
| DOI | 10.34071/jmp.2025.5.1 | |
| Keywords | vi khuẩn Nontuberculous mycobacteria (NTM), dịch tễ nhiễm trùng do NTM, chẩn đoán và điều trị bệnh phổi do NTM Nontuberculous mycobacteria (NTM), pathology NTM, diagnosing and treating NTM-PD |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Hue Journal of Medicine and Pharmacy
Johnson TM, Byrd TF, Drummond WK, Childs-Kean LM, Mahoney MV, Pearson JC, et al. Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review. Infectious Diseases and Therapy. 2023;12(2):343-65.
Griffith DE. Overview of nontuberculous mycobacterial infections.
Pyarali FF, Schweitzer M, Bagley V, Salamo O, Guerrero A, Sharifi A, et al. Increasing Non-tuberculous Mycobacteria Infections in Veterans With COPD and Association With Increased Risk of Mortality. Frontiers in Medicine. 2018;5:311.
Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015. Annals of the American Thoracic Society. 2020;17(2):178-85.
Dahl VN, Mølhave M, Fløe A, Van Ingen J, Schön T, Lillebaek T, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. International Journal of Infectious Diseases. 2022;125:120-31.
Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan1. Emerging Infectious Diseases. 2016;22(6):1116-7.
Schildkraut JA, Gallagher J, Morimoto K, Lange C, Haworth C, Floto RA, et al. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respiratory Medicine. 2020;173:106164.
Chaptal M, Andrejak C, Bonifay T, Beillard E, Guillot G, Guyomard-Rabenirina S, et al. Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008–2018. PLOS Neglected Tropical Diseases. 2022;16(9):e0010693.
Hoàng Thị Phượng. Cẩm nang thực hành lâm sàng bệnh nhiễm trùng Nontuberculous Mycobacteria: Đại học quốc gia Hà Nội; 2022 2022.
Hoàng Thị Phượng. Tổng quan về cập nhật chẩn đoán và điều trị bệnh phổi do nontuberculous mycobacteria tiếp cận thực hành lâm sàng. 129. 2022 11-2022.
Griffith DE. Diagnosis of nontuberculous mycobacterial infections of the lungs. Wolters Kluwer, https://www.uptodate.com/contents/diagnosis-of-nontuberculous-mycobacterial-infections-of-the-lungs, truy cập ngày 5/5/2025
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine. 2007;175(4):367-416.
Griffith DE, Daley CL. Introducing the Nontuberculous Mycobacteria Series for CHEST. CHEST. 2022;161(1):1-2.
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1-ii64.
Cheng L-P, Chen S-H, Lou H, Gui X-W, Shen X-N, Cao J, et al. Factors Associated with Treatment Outcome in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Large Population-Based Retrospective Cohort Study in Shanghai. Tropical Medicine and Infectious Disease. 2022;7(2):27.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clinical Infectious Diseases. 2020;71(4):e1-e36.
Bộ Y tế. Hướng dẫn chẩn đoán, điều trị và dự phòng bệnh lao. 2024.
Yan Y, Wu L, Li X, Zhao L, Xu Y. Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury. Frontiers in Oncology. 2023;13:966060.
Hamed KA, Tillotson G. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges. Expert Review of Respiratory Medicine. 2023;17(11):973-88.